Koelsch Bernd U, Kindler-Röhrborn Andrea, Held Sabine, Zabel Simone, Rajewsky Manfred F
Institute of Cell Biology (Cancer Research), University of Essen Medical School and West German Cancer Center Essen, Hufeland-Strasse 55, D-45122 Essen, Germany.
Carcinogenesis. 2002 Jun;23(6):1033-7. doi: 10.1093/carcin/23.6.1033.
Rats of the inbred BD strains strongly differ in their susceptibility to the induction of tumors of the central (CNS) and peripheral nervous system (PNS) by N-ethyl-N-nitrosourea (EtNU). Malignant schwannomas induced in (BDIX x BDIV) and (BDIX x BDVI) rat hybrids were analyzed to identify genetic alterations associated with EtNU-induced tumorigenesis in the PNS. EtNU-induced schwannomas exclusively exhibit an A:T T:A transversion mutation of the neu/Erbb-2 gene located on chromosome 10, with subsequent loss of the wild-type neu/Erbb-2 allele at a post-initiation stage. Targeted allelic deletion mapping previously revealed losses of heterozygosity (LOH) at the distal end of chromosome 10 in a large majority of (BDIX x BDIV) schwannomas. The aims of the present study were (i) to scan the whole genome for further LOHs; (ii) to narrow down the consensus regions of frequently occurring allelic deletions using tumors from different crosses of BD rats; and (iii) to determine the sequence of genetic alterations during schwannoma development. A limited number of (BDIX x BDIV) F(1) tumors were initially screened for LOH and microsatellite instability (MI) by amplifying 58 microsatellite markers spanning the whole genome. LOHs on chromosome 5 were detected in 9/17 tumors, with random loss of the parental alleles. Ninety-two schwannomas from different BD rat-crosses were then analyzed to solidify these data and to determine the consensus region of frequent LOHs. The results indicate that LOHs on chromosomes 10 and 5 are required for the development of EtNU-induced malignant schwannomas from immature neu/Erbb-2 mutant glial cells, and that putative tumor suppressor genes are localized on chromosome 10q32.3, corresponding to human chromosome 17q25.3, and the telomeric region of mouse chromosome 11, and on the telomeric quarter of chromosome 5. MI was detected in <0.2% of cases.
近交系BD大鼠对N-乙基-N-亚硝基脲(EtNU)诱导中枢神经系统(CNS)和外周神经系统(PNS)肿瘤的易感性差异很大。分析了在(BDIX×BDIV)和(BDIX×BDVI)大鼠杂交种中诱导产生的恶性神经鞘瘤,以确定与EtNU诱导的PNS肿瘤发生相关的基因改变。EtNU诱导的神经鞘瘤仅表现出位于10号染色体上的neu/Erbb-2基因的A:T到T:A颠换突变,随后在起始后阶段野生型neu/Erbb-2等位基因丢失。靶向等位基因缺失图谱先前显示,在大多数(BDIX×BDIV)神经鞘瘤中,10号染色体远端存在杂合性缺失(LOH)。本研究的目的是:(i)扫描全基因组以寻找更多的LOH;(ii)使用来自不同BD大鼠杂交组合的肿瘤缩小频繁发生等位基因缺失的共有区域;(iii)确定神经鞘瘤发生过程中的基因改变序列。最初通过扩增覆盖全基因组的58个微卫星标记,对有限数量的(BDIX×BDIV)F(1)肿瘤进行了LOH和微卫星不稳定性(MI)筛查。在17个肿瘤中的9个中检测到5号染色体上的LOH,亲本等位基因随机丢失。然后分析了来自不同BD大鼠杂交组合的92个神经鞘瘤,以巩固这些数据并确定频繁LOH的共有区域。结果表明,从不成熟的neu/Erbb-2突变神经胶质细胞发展为EtNU诱导的恶性神经鞘瘤需要10号和5号染色体上的LOH,并且假定的肿瘤抑制基因位于10q32.3,对应于人类染色体17q25.3以及小鼠染色体11的端粒区域,以及5号染色体的端粒四分之一区域。在<0.2%的病例中检测到MI。